Education
About Us
Working with TipRanks
Follow Us
Kala Pharmaceuticals (KALA)
:KALA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 3.89M | $ 11.24M | $ 6.36M |
| Gross Profit | $ 0.00 | $ -303.00K | $ 1.33M | $ 7.14M | $ 3.19M |
| Operating Income | $ -40.98M | $ -39.15M | $ -81.36M | $ -109.43M | $ -96.23M |
| EBITDA | $ -40.98M | $ -36.08M | $ -36.70M | $ -131.96M | $ -92.90M |
| Net Income | $ -38.51M | $ -42.20M | $ -223.00K | $ -152.30M | $ -112.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 51.18M | $ 50.90M | $ 70.50M | $ 92.14M | $ 153.54M |
| Total Assets | $ 55.48M | $ 55.95M | $ 86.82M | $ 139.43M | $ 221.61M |
| Total Debt | $ 32.25M | $ 36.32M | $ 42.95M | $ 80.19M | $ 100.92M |
| Net Debt | $ -18.93M | $ -14.57M | $ -27.55M | $ -11.95M | $ 23.65M |
| Total Liabilities | $ 43.15M | $ 48.45M | $ 67.85M | $ 122.62M | $ 121.61M |
| Stockholders' Equity | $ 12.33M | $ 7.50M | $ 18.97M | $ 16.80M | $ 100.00M |
| Cash Flow | |||||
| Free Cash Flow | $ -29.59M | $ -28.54M | $ -79.22M | $ -109.12M | $ -92.64M |
| Operating Cash Flow | $ -29.38M | $ -27.93M | $ -78.91M | $ -108.23M | $ -90.69M |
| Investing Cash Flow | $ -208.00K | $ -429.00K | $ 62.72M | $ 70.80M | $ -78.21M |
| Financing Cash Flow | $ 29.88M | $ 8.51M | $ -7.94M | $ 42.55M | $ 160.63M |